Laccure AB has developed a product for women with bacterial vaginosis. Due to its extended release of lactic acid, one vaginal tablet is the entire treatment! Its safety and efficacy has been confirmed in clinical trials, performed according to ICH GCP. The product is classified as a medical device IIb. Laccure AB is one of several project companies of Aqilion AB (former PULS AB). For further information see www.laccure.com
| Website | http://www.laccure.com |
| Revenue | $2 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2007 |
| Address | 8 Kullagatan, Helsingborg, Skane 252 20, SE |
| Phone | +46 70 523 01 01 |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Building Materials, Biotechnology, Manufacturing, Science and Engineering, Health Care, Pharmaceutical |
| Keywords | Vaginal Health, Womens Health, Gynecological Care, Womens Health Solutions, Feminine Hygiene, Reproductive Health |
| Competitors | Roche, Novartis, AstraZeneca, Boehringer Ingelheim, UCB, Ferring Pharmaceuticals, Elekta, Sobi - Swedish Orphan Biovitrum AB (publ), MedImmune, Mecas +37 more (view full list) |
| SIC | SIC Code 34 Companies, SIC Code 346 Companies |
| NAICS | NAICS Code 332 Companies, NAICS Code 33 Companies |
Looking for a particular Laccure AB employee's phone or email?
Laccure AB Questions
The Laccure AB annual revenue was $2 million in 2026.
Laccure AB is based in Helsingborg, Skane.
The NAICS codes for Laccure AB are [332, 33].
The SIC codes for Laccure AB are [34, 346].
Related Companies
